Home/Filings/4/0000899243-21-006402
4//SEC Filing

Green John L. 4

Accession 0000899243-21-006402

CIK 0001622229other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:17 PM ET

Size

8.0 KB

Accession

0000899243-21-006402

Insider Transaction Report

Form 4
Period: 2021-02-10
Green John L.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-10+111,300111,300 total
    Exercise: $10.17Exp: 2031-02-10Common Stock (111,300 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-10+270,746270,746 total
    Exercise: $10.17Exp: 2031-02-10Common Stock (270,746 underlying)
Footnotes (2)
  • [F1]This stock option shall vest in equal monthly installments over a four year period.
  • [F2]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001709773

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 8:17 PM ET
Size
8.0 KB